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A 74-year-old man, nonsmoker, presented with asthenia,inappetence, weight loss (about 10 kilograms in the last 6
months), right chest pain and some episodes of hemoptysis
without fever.
Routine laboratory tests showed increased ESR (107
mm/h) and LDH (783 UI/L). Serum tumor markers (CEA,
CA19.9) were negative. In 1958, the patient had undergone
artificial right pneumothorax for tuberculosis with develop-
ment of a chronic right pyothorax (Figure 1A).
A more recent chest CT confirmed the presence of a
huge right pyothorax surrounded by a fibrous wall with
calcifications and different nodular masses (up to 5 cm
across) with soft-tissue enhancement determining external
compression of the medium and lower lobar bronchi (Figure
1B). The patient underwent a transthoracic biopsy of the
masses. At histology, biopsy showed a monotonous prolifer-
ation of medium-to-large cells with evident nucleoli in a
necrotic and hemorrhagic background (Figure 1C). Tumor
cells were positive for LCA, CD20, CD3, CD79a and PAX-5,
but negative for cytokeratins, CD138, CD30, ALK, HHV-8,
MPO, CD68. Labeling index by MIB-1 was very high (85%)
and EBER probe by in situ hybridization showed numerous
stained nuclei then confirming the presence EBV genome. A
diagnosis of pyothorax-associated large B cell lymphoma was
performed. The patient, alive with disease, appeared in a very
poor performance status and denied any further therapy.
DISCUSSION
Pyothorax-associated lymphoma (PAL) is a rare dis-
tinct variant of diffuse large B-cell lymphoma first described
in 1987 by Aozasa et al. It mainly occurs in 60–70 year-old
Japanese people, and much more rarely in Caucasian patients,
with marked male gender prevalence and a longstanding
history (20–67 years) of pyothorax or chronic pleuritis due to
artificial pneumothorax for pleuro-pulmonary tuberculosis.2
Patients clinically present with weight loss and chest
pain, while imaging studies reveal pleural effusion and pleu-
ral thickening and/or masses. High level of serum NSE has
been observed in some cases, then erroneously suggesting a
small-cell carcinoma.2
At morphology, PAL appears as a monotonous pro-
liferation of medium-to-large sized nucleolated cells with
amphophilic cytoplasm and immunoblastic/plasmablastic
appearance. These cells show a very high labeling index by
Ki-67/MIB-1 (80 –90%) and are positive for pan-B mark-
ers (CD20, CD79a, PAX-5) also variably co-expressing
T-cell markers (CD2, CD3, CD7) and CD138, but not
CD30 and ALK, then revealing a post/late germinal center
B cell derivation.3
PAL seems to be driven by EBV infection or less
frequently by HHV-8. So, EBV may be likely detected by
LMP-1 or EBNA2 expression or EBER probe by in-situ
hybridization.2,4
Differential diagnosis on clinical and imaging grounds
is quite broad. Primary pleural solid (mesothelioma, solitary
fibrous tumors, synovial sarcoma, angiosarcoma) or meta-
static tumors may mimic PAL. Correct diagnosis always
require knowledge of the patient past medical history (tuber-
culous pleuritis treated by pneumothorax), a good biopsy
(even obtained by transthoracic needle biopsy as first reported
in our case) and appropriate ancillary studies (immunohisto-
chemistry and molecular analysis). Once lymphoma is sus-
pected, differential diagnosis should mainly posed in regards
with primary effusion lymphoma (PEL). This latter, by con-
trast, occurs in patients with HIV infection clinically present-
ing with massive effusions of the body cavities without
evidence of neoplastic masses. PEL cells are negative for
B-cell and T-cell markers, whereas they express HHV-8 but
not EBV in virtually all cases.
Although no well-established therapy exists and
prognosis is very dismal (5-year survival accounts for
21.6% in the largest series),5 PAL patients are generally
treated by different combinations of chemotherapy and
radiotherapy. Of note, local irradiation seems to control
the disease.2,5
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FIGURE 1. Chest CT (performed in 2003) showing a right pleural pyothorax with peripheral calcifications (A). A recent chest
CT (in May 2007) revealing the presence of nodular masses with homogeneous nonenhancing soft tissue signal attenuation
developed around the pyothorax and infiltrating the lung parenchyma (B, C). Histologic examination of the masses consisted
of a monotonous proliferation of medium-to-large lymphoid cells (D, hematoxylin-eosin X200) showing positive nuclear stain-
ing for EBV (E, EBER probe, in-situ hybridization X200).
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